(2023)
Co-occurrence of leukemia, Crohn’s disease, and tuberous sclerosis in one patient.
Precision and Future Medicine.
1,
1
(2023)
Pyogenic liver abscess as an extra-intestinal manifestation of pediatric Crohn’s disease.
Precision and Future Medicine.
1,
1
(2023)
Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study.
BIOMEDICINES.
11,
9
(2023)
Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation.
FRONTIERS IN MEDICINE.
10,
1
(2023)
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum.
ANNALS OF DERMATOLOGY.
35,
1
(2023)
Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn’s disease patients with secondary loss of response.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY.
1,
1
(2022)
Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study.
GUT AND LIVER.
16,
6
(2022)
Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission.
FRONTIERS IN IMMUNOLOGY.
13,
1
(2022)
Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS.
56,
7
(2022)
Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
37
(2022)
Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease.
BIOMEDICINES.
10,
10
(2022)
Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease.
THERAPEUTIC DRUG MONITORING.
44,
4
(2022)
How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study.
WORLD JOURNAL OF GASTROENTEROLOGY.
28,
28
(2022)
Fluoroscopic criteria for on-site evaluation of failed intussusception reduction during air enema technique.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY.
12,
7
(2022)
Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children.
FRONTIERS IN PEDIATRICS.
10,
1
(2022)
Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations.
FRONTIERS IN PEDIATRICS.
10,
1
(2022)
NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS.
55,
8
(2022)
Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission.
SCIENTIFIC REPORTS.
12,
1
(2021)
Preparing for medical education after the COVID-19 pandemic: insightology in medicine.
KOREAN JOURNAL OF MEDICAL EDUCATIONKOREAN SOCIETY OF MEDICAL EDUCATION.
33,
3
(2021)
Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.
FRONTIERS IN IMMUNOLOGY.
12,
1
단행본
(2020)
기억 안아주기 (소확혐, 작지만 확실히 나쁜 기억).
글항아리.
단독
(2016)
Helicobacter pylori.
Springer.
공동
학술회의논문
(2023)
한국 소아 궤양성 대장염의 진단시 특성: 다기관, 레지스트리 기반 코호트 연구 결과.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
성장부전(FTT)의 평가 및 상담.
2023년 대한소아소화기영양학회 제20차 워크숍.
대한민국
(2023)
Associations between factors at diagnosis in paediatric patients with Crohn's disease: results from a multicentre, registry-basesd, inception cohort study.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
Changes in the Prevalences of Obesity, dyslipidemia and Non-Alcoholic Fatty Liver Disease among Korean Children and Adolescents during the COVID-19 pandemic: Data from the Korea National Health and Nutrition Examination Survey 2017-2021.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
Disease duration is associated with endoscopic healing in pediatric patients with Crohn's disease on teatment with infliximab.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
Therapeutic drug monitoring-based proactive dosing is superior to clinically-based dosing in terms of endoscopic healing in pediatric patients with Crohn's disease receiving maintenance infliximab: A randomized controlled trial.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
깊은 관해를 유지하는 소아 크론병 환자에서 생물학적 제제 중단 후 재발하는 기간에 영향을 미치는 위험요인들에 대한 분석.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
생물학제제에 역설 반응을 보인 소아청소년 염증성 장질환 환자군의 임상적 특성 조사 (단일 기관 후향적 연구).
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
소아 크론병 환자에서 메토트렉세이트에 대한 반응의 임상 예측인자.
차 대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
소아 크론병에서 infliximab plus azathioprine 병용요법과 infliximab 단독요법의 내시경 치유 및 durability 비교 연구.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
소아 크론병에서 infliximab trough 및 항체 농도에 영향을 미치는 치료 1년시점의 사이토카인 분석: 후속 연구.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
소아 크론병의 기존 치료법 반응과 관련된 위험 인자 분석: 전국 레지스트리 기반 후향 코호트 연구.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
Factors associated with time-to-perianal surgery after diagnosis in paediatric patients with Crohn's disease.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
TSC 1 유전자의 병원성 변이를 가진 환자에서 백혈병, 크론병 및 결절성 경화증의 발생.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
Three perspectives on functional abdominal pain in children.
대한소아청소년과학회 추계학술대회.
대한민국
(2023)
latrogenesis, familiogenesis, and iatrofamiliogenesis: three cores getting access to functional abdominal pain in children.
대한소아청소년과학회 추계학술대회.
대한민국
(2023)
국내 소아 크론병 환자에서 상부 위장관 침범의 임상적 중요성에 대한 연구.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
(2023)
급성충수돌기염 증상으로 수술적 치료 후 크론병으로 진단받은 소아청소년 환자 증례.
대한소아청소년과학회 추계학술대회 초록집.
대한민국
